Skip to main content
. 2021 Sep 6;13(6):1582–1591. doi: 10.1177/21925682211041968

Table 1.

Characteristics of Non-Chronic and Chronic Opioid Users Preoperatively.

Non-chronic (N = 233) Chronic (N = 27) P-value1
Age 64.0 [54.0,70.0] 59.0 [54.0,66.0] .29
Sex .93
 M 145 (62.2%) 16 (59.3%)
 F 88 (37.8%) 11 (40.7%)
BMI >35 40 (17.2%) 5 (18.5%) .86
Smoking .15
 Non- 141 (60.5%) 21 (77.8%)
 Former 26 (11.2%) 3 (11.1%)
 Current 66 (28.3%) 3 (11.1%)
Follow-up (months) 12.7 [11.7,13.7] 14.0 [12.8,15.2] <.001*
Preoperative diagnosis: .79
 Spondylolisthesis 137 (58.8%) 15 (55.6%)
 Scoliosis 35 (15.0%) 6 (22.2%)
 Disk herniation 40 (17.2%) 4 (14.8%)
 Stenosis 21 (9.01%) 2 (7.41%)
Workers’ compensation received .48
 No 112 (48.1%) 10 (37.0%)
 Yes 12 (5.15%) 1 (3.70%)
 Not working before surgery 109 (46.8%) 16 (59.3%)
Insurance status .99
 Medicare 107 (45.9%) 13 (48.1%)
 Private/other 126 (54.1%) 14 (51.9%)
Past mental history .02*
 Neither 202 (86.7%) 18 (66.7%)
 Depression only 12 (5.15%) 4 (14.8%)
 Anxiety only 5 (2.15%) 0 (.00%)
 Depression and anxiety 14 (6.01%) 5 (18.5%)
 Max. distance travelled (mi.) .00 [.00,2.90] 4.08 [.00,11.8] <.001*
Total prescriptions 1.00 [.00,3.00] 12.0 [8.50,26.5] <.001*
Total # of prescribers 1.00 [.00,2.00] 3.00 [2.00,4.50] <.001*
Duration of usage (Days) 3.00 [.00,23.0] 240 [158 400] <.001*
# Of pills or tablets 18.0 [.0, 93.5] 870 [405, 1730] <.001*
Total # of pharmacies 1.00 [.00,1.00] 2.00 [1.00,3.00] <.001*
Daily dose MME. 15.0 [.00,57.1] 80.1 [28.4,294] <.001*

1Mann–Whitney U or Pearson’s Chi-Square test to compare medians between groups. Overall baseline demographics and preoperative consumption parameters are listed as either: Median and [IQR] or total counts and percent. *Indicates statistical significance (P<.05). Bold indicates category heading, where non-bold indicates subheading.